These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2433021)
1. Cis-platinum(II) complexes of carboxymethyl-dextran as potential antitumor agents. I. Preparation and characterization. Schechter B; Pauzner R; Arnon R; Wilchek M Cancer Biochem Biophys; 1986 Oct; 8(4):277-87. PubMed ID: 2433021 [TBL] [Abstract][Full Text] [Related]
2. Cis-platinum (II) complexes of carboxymethyl-dextran as potential antitumor agents. II. In vitro and in vivo activity. Schechter B; Pauzner R; Wilchek M; Arnon R Cancer Biochem Biophys; 1986 Oct; 8(4):289-98. PubMed ID: 2433022 [TBL] [Abstract][Full Text] [Related]
3. Selective cytotoxicity against tumor cells by cisplatin complexed to antitumor antibodies via carboxymethyl dextran. Schechter B; Pauzner R; Arnon R; Haimovich J; Wilchek M Cancer Immunol Immunother; 1987; 25(3):225-30. PubMed ID: 2445485 [TBL] [Abstract][Full Text] [Related]
4. Blood levels and serum protein binding of cis-platinum(II) complexed to carboxymethyl-dextran. Schechter B; Rosing MA; Wilchek M; Arnon R Cancer Chemother Pharmacol; 1989; 24(3):161-6. PubMed ID: 2472228 [TBL] [Abstract][Full Text] [Related]
5. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs. Hacker MP; Khokhar AR; Brown DB; McCormack JJ; Krakoff IH Cancer Res; 1985 Oct; 45(10):4748-53. PubMed ID: 4040806 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxic activity of dextran carrying cis-dichloro(cyclohexane-trans-l-1,2-diamine)platinum(II) complex. Ohya Y; Masunaga T; Baba T; Ouchi T J Biomater Sci Polym Ed; 1996; 7(12):1085-96. PubMed ID: 8880440 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers. Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964 [TBL] [Abstract][Full Text] [Related]
8. Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity. Plooy AC; van Dijk M; Lohman PH Cancer Res; 1984 May; 44(5):2043-51. PubMed ID: 6538808 [TBL] [Abstract][Full Text] [Related]
9. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition. Bodenner DL; Dedon PC; Keng PC; Borch RF Cancer Res; 1986 Jun; 46(6):2745-50. PubMed ID: 2870800 [TBL] [Abstract][Full Text] [Related]
10. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat. de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of DNA complexation with antitumor therapeutic cis-DDP and binuclear bivalent platinum compound containing pyrazine]. Kas'ianenko NA; Aĭa EE; Bogdanov AA; Kosmotynskaia IuV; Iakovlev KI Mol Biol (Mosk); 2002; 36(4):745-52. PubMed ID: 12173482 [TBL] [Abstract][Full Text] [Related]
13. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents. Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370 [TBL] [Abstract][Full Text] [Related]
14. [Structure-activity relations of antineoplastic platinum II and platinum IV coordination compounds]. Gutsche W; Baumgart J; Schröer HP Arch Geschwulstforsch; 1989; 59(4):233-8. PubMed ID: 2802931 [TBL] [Abstract][Full Text] [Related]
15. Mutagenicity, tumorigenicity, and electrophilic reactivity of the stereoisomeric platinum(II) complexes of 1,2-diaminocyclohexane. Leopold WR; Batzinger RP; Miller EC; Miller JA; Earhart RH Cancer Res; 1981 Nov; 41(11 Pt 1):4368-77. PubMed ID: 7030475 [TBL] [Abstract][Full Text] [Related]
16. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts. Roberts JJ; Friedlos F Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217 [TBL] [Abstract][Full Text] [Related]
17. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids. Lippert B Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842 [TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of the cis-diamminedichloroplatinum(II)--cysteine reaction: implications to the extent of platinum--DNA binding. Bose RN; Ghosh SK; Moghaddas S J Inorg Biochem; 1997 Feb; 65(3):199-205. PubMed ID: 9025271 [TBL] [Abstract][Full Text] [Related]
19. Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands. Zorbas-Seifried S; Jakupec MA; Kukushkin NV; Groessl M; Hartinger CG; Semenova O; Zorbas H; Kukushkin VY; Keppler BK Mol Pharmacol; 2007 Jan; 71(1):357-65. PubMed ID: 17050805 [TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro effectivity of some platinum complexes. Balázová E; Hrubisko M; Ujházy V Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]